SITPIN D 10/100
SITPIN D 10/100 is a combination therapy used for effective control of type 2 diabetes mellitus. Each film-coated tablet contains Sitagliptin 100 mg + Dapagliflozin 10 mg. Sitagliptin improves insulin secretion and reduces glucagon levels, while Dapagliflozin helps eliminate excess glucose through urine. This dual mechanism supports better glycemic control, helps reduce HbA1c levels, and contributes to improved overall metabolic health in diabetic patients.
Related products
SITAMATA 50- 1000
SITAMATA 50-1000 contains Sitagliptin 50 mg + Metformin Hydrochloride 1000 mg, a strong dual-action combination...
LINANTA 5
LINANTA 5 contains Linagliptin 5 mg, an effective DPP-4 inhibitor used in the management of...
GLYZIL M
GLYZIL M is a trusted combination for managing type 2 diabetes mellitus effectively. Each tablet...
DUET ACT 3
DUET ACT 3 Tablet is a combination medicine used for managing type 2 diabetes. It...
DAPAGLIDE M 1000
DAPAGLIDE M 1000 Tablet is a combination medicine used for managing type 2 diabetes effectively....
DAPAGLIDE 10
DAPAGLIDE 10 Tablet contains Dapagliflozin 10 mg, an advanced medicine used to manage type 2...
DAPAGLIDE 5
DAPAGLIDE 5 Tablet contains Dapagliflozin 5 mg, a modern anti-diabetic medicine used in the management...
